• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症中缺氧(18)F-氟莫司汀动态 PET 的药代动力学分析。

Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.

机构信息

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

出版信息

J Nucl Med. 2010 Jan;51(1):37-45. doi: 10.2967/jnumed.109.067009. Epub 2009 Dec 15.

DOI:10.2967/jnumed.109.067009
PMID:20008982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2828684/
Abstract

UNLABELLED

This study used pharmacokinetic analysis of (18)F-labeled fluoromisonidazole ((18)F-FMISO) dynamic PET to assist the identification of regional tumor hypoxia and to investigate the relationship among a potential tumor hypoxia index (K(i)), tumor-to-blood ratio (T/B) in the late-time image, plasma-to-tissue transport rate (k(1)), and local vascular volume fraction (beta) for head and neck cancer patients.

METHODS

Newly diagnosed patients underwent a dynamic (18)F-FMISO PET scan before chemotherapy or radiotherapy. The data were acquired in 3 consecutive PET/CT dynamic scan segments, registered with each other and analyzed using pharmacokinetics software. The (K(i), k(1), beta) kinetic parameter images were derived for each patient.

RESULTS

Nine patients' data were analyzed. Representative images of (18)F-FDG PET (of the tumor), CT (of the anatomy), and late-time (18)F-FMISO PET (of the T/B) and parametric images of K(i) (potentially representing tumor hypoxia) are shown. The patient image data could be classified into 3 types: with good concordance between the parametric hypoxia map K(i) and high T/B, with concordant findings between the parametric hypoxia map and low T/B, and with ambiguity between parametric hypoxia map and T/B. Correlation coefficients are computed between each pair of T/B, K(i), k(1), and beta. Data are also presented for other potential hypoxia surrogate measures, for example, k(3) and k(1)/k(2).

CONCLUSION

There is a positive correlation of 0.86 between the average T/B and average hypoxia index K(i) of the region of interest. However, because of the statistical photon counting noise in PET and the amplification of noise in kinetic analysis, the direct correlation between the T/B and hypoxia of the individual pixel is not obvious. For a tumor region of interest, there is a slight negative correlation between k(1) and K(i), moderate positive correlation between beta and K(i), but no correlation between beta and k(1).

摘要

目的

本研究使用(18)F 标记氟米索硝唑((18)F-FMISO)动态 PET 的药代动力学分析来辅助识别局部肿瘤缺氧,并探讨潜在肿瘤缺氧指数(K(i))、晚期图像肿瘤与血液比(T/B)、血浆与组织转运率(k(1))和局部血管体积分数(β)之间的关系。

方法

新诊断的患者在化疗或放疗前进行动态(18)F-FMISO PET 扫描。数据在 3 个连续的 PET/CT 动态扫描段中采集,相互配准并使用药代动力学软件进行分析。为每位患者生成(K(i),k(1),β)动力学参数图像。

结果

分析了 9 名患者的数据。展示了(18)F-FDG PET(肿瘤)、CT(解剖结构)、晚期(18)F-FMISO PET(T/B)和 K(i)(潜在代表肿瘤缺氧)参数图像的代表性图像。患者图像数据可分为 3 种类型:参数缺氧图 K(i)与高 T/B 之间有很好的一致性,参数缺氧图与低 T/B 之间有一致性,参数缺氧图与 T/B 之间有模糊性。计算了 T/B、K(i)、k(1)和β之间的每对相关系数。还提供了其他潜在缺氧替代指标的数据,例如 k(3)和 k(1)/k(2)。

结论

感兴趣区域的平均 T/B 与平均缺氧指数 K(i)之间存在 0.86 的正相关。然而,由于 PET 中的统计光子计数噪声和动力学分析中噪声的放大,个体像素的 T/B 与缺氧之间的直接相关性不明显。对于肿瘤感兴趣区域,k(1)与 K(i)之间存在轻微负相关,β与 K(i)之间存在中度正相关,但β与 k(1)之间无相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/593150ddf62c/nihms178747f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/0435cc0860ff/nihms178747f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/9b5f4619c546/nihms178747f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/517dcf67497a/nihms178747f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/9cb2f7c02c36/nihms178747f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/29b000ac494d/nihms178747f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/593150ddf62c/nihms178747f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/0435cc0860ff/nihms178747f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/9b5f4619c546/nihms178747f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/517dcf67497a/nihms178747f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/9cb2f7c02c36/nihms178747f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/29b000ac494d/nihms178747f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e1b/2828684/593150ddf62c/nihms178747f6.jpg

相似文献

1
Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.头颈部癌症中缺氧(18)F-氟莫司汀动态 PET 的药代动力学分析。
J Nucl Med. 2010 Jan;51(1):37-45. doi: 10.2967/jnumed.109.067009. Epub 2009 Dec 15.
2
Multiparametric Imaging of Tumor Hypoxia and Perfusion with F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.头颈部癌中使用F-氟米索硝唑动态PET对头颈部肿瘤缺氧和灌注进行多参数成像
J Nucl Med. 2017 Jul;58(7):1072-1080. doi: 10.2967/jnumed.116.188649. Epub 2017 Feb 9.
3
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.18F-氟咪索硝唑 PET 评估头颈部肿瘤缺氧的高重复性。
J Nucl Med. 2013 Feb;54(2):201-7. doi: 10.2967/jnumed.112.109330. Epub 2013 Jan 15.
4
Monitoring early response to chemoradiotherapy with F-FMISO dynamic PET in head and neck cancer.利用F-FMISO动态PET监测头颈部癌放化疗的早期反应
Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1682-1691. doi: 10.1007/s00259-017-3720-6. Epub 2017 May 24.
5
Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.头颈部癌血流与缺氧的影像学检查:用[(15)O]H₂O和[(18)F]氟代erythronitroimidazole正电子发射断层显像进行初步评估
J Nucl Med. 2001 Nov;42(11):1643-52.
6
Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.头颈部癌中(18)F-氟米索硝唑PET检查结果与缺氧诱导因子-1α(HIF-1α)及p53表达的相关性:与(18)F-氟代脱氧葡萄糖(FDG)PET的比较
Nucl Med Commun. 2014 Jan;35(1):30-5. doi: 10.1097/MNM.0000000000000010.
7
Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer.(18)F-氟米索硝唑在头颈部肿瘤内分布的可重复性
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):235-42. doi: 10.1016/j.ijrobp.2007.08.036.
8
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.非小细胞肺癌中动态F-氟米索硝唑PET数据的药代动力学分析
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.
9
Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times.使用缩短采集时间的18F-氟米索硝唑动力学模型对头颈部癌进行研究的可行性。
J Nucl Med. 2016 Mar;57(3):334-41. doi: 10.2967/jnumed.115.160168. Epub 2015 Nov 25.
10
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.调强放疗分次照射对头颈部癌缺氧再氧合及葡萄糖代谢的影响
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2147-2154. doi: 10.1007/s00259-016-3431-4. Epub 2016 Jun 1.

引用本文的文献

1
Multidimensional in silico evaluation of fluorine-18 radiopharmaceuticals: integrating pharmacokinetics, ADMET, and clustering for diagnostic stratification.氟-18放射性药物的多维计算机模拟评估:整合药代动力学、药物代谢及毒性预测和聚类分析用于诊断分层
J Comput Aided Mol Des. 2025 Sep 3;39(1):75. doi: 10.1007/s10822-025-00655-8.
2
Kinetic Evaluation of the Hypoxia Radiotracers [F]FMISO and [F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging.使用动态PET/CT成像对患有自发性肿瘤的犬类进行缺氧放射性示踪剂[F]FMISO和[F]FAZA的动力学评估。
Nucl Med Mol Imaging. 2023 Feb;57(1):16-25. doi: 10.1007/s13139-022-00780-4. Epub 2022 Oct 11.
3

本文引用的文献

1
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging.通过氟代米索硝唑(FMISO)动态正电子发射断层扫描(PET)成像评估用于估计肿瘤缺氧的房室模型。
Phys Med Biol. 2009 May 21;54(10):3083-99. doi: 10.1088/0031-9155/54/10/008. Epub 2009 May 6.
2
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?极谱氧测定法、对比增强彩色双功超声检查(CDS)、[18F]氟米索硝唑和[18F]氟脱氧葡萄糖正电子发射断层扫描:评估与治疗相关的肿瘤氧合的有效方法,还是仅仅是肿瘤缺氧难题中的几块拼图?
BMC Cancer. 2007 Jun 28;7:113. doi: 10.1186/1471-2407-7-113.
3
Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations.
生物成像引导的纳米药物临床转化的药物评价。
J Nanobiotechnology. 2022 May 19;20(1):236. doi: 10.1186/s12951-022-01451-4.
4
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic F-FMISO PET for Head and Neck Cancer Radiotherapy.基于动态 F-FMISO PET 的头颈部癌症放疗的肿瘤控制概率模型的前瞻性评估。
J Nucl Med. 2019 Dec;60(12):1698-1704. doi: 10.2967/jnumed.119.227744. Epub 2019 May 10.
5
Towards clinically translatable nanodiagnostics.迈向临床可转化的纳米诊断技术。
Nat Rev Mater. 2017 May;2(5). doi: 10.1038/natrevmats.2017.14. Epub 2017 May 3.
6
Impact of tissue transport on PET hypoxia quantification in pancreatic tumours.组织运输对胰腺肿瘤PET缺氧定量分析的影响。
EJNMMI Res. 2017 Dec 22;7(1):101. doi: 10.1186/s13550-017-0347-3.
7
F-fluoromisonidazole uptake in advanced stage non-small cell lung cancer: A voxel-by-voxel PET kinetics study.晚期非小细胞肺癌氟-氟莫司汀摄取:体素 PET 动力学研究。
Med Phys. 2017 Sep;44(9):4665-4676. doi: 10.1002/mp.12416. Epub 2017 Jul 21.
8
Hypoxia imaging and radiotherapy: bridging the resolution gap.缺氧成像与放射治疗:弥合分辨率差距
Br J Radiol. 2017 Aug;90(1076):20160939. doi: 10.1259/bjr.20160939. Epub 2017 May 25.
9
Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.非小细胞肺癌中动态F-氟米索硝唑PET数据的药代动力学分析
J Nucl Med. 2017 Jun;58(6):911-919. doi: 10.2967/jnumed.116.180422. Epub 2017 Feb 23.
10
Pharmacokinetic modeling of a novel hypoxia PET tracer [F]HX4 in patients with non-small cell lung cancer.新型缺氧正电子发射断层显像示踪剂[F]HX4在非小细胞肺癌患者中的药代动力学建模
EJNMMI Phys. 2016 Dec;3(1):30. doi: 10.1186/s40658-016-0167-y. Epub 2016 Dec 12.
Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.使用(18)F-米索硝唑和正电子发射断层扫描进行缺氧成像:头颈部癌放疗期间的动力学变化
Radiother Oncol. 2007 Jun;83(3):406-10. doi: 10.1016/j.radonc.2007.05.014. Epub 2007 May 31.
4
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.头颈部癌中使用[F-18]氟米索硝唑正电子发射断层扫描进行肿瘤缺氧成像。
Clin Cancer Res. 2006 Sep 15;12(18):5435-41. doi: 10.1158/1078-0432.CCR-05-1773.
5
Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.动态18F-氟米索硝唑PET的动力学分析与头颈癌放疗结果相关。
BMC Cancer. 2005 Dec 1;5:152. doi: 10.1186/1471-2407-5-152.
6
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.397例头颈部肿瘤原发放疗后肿瘤氧合的预后价值:一项国际多中心研究
Radiother Oncol. 2005 Oct;77(1):18-24. doi: 10.1016/j.radonc.2005.06.038. Epub 2005 Aug 10.
7
A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.用于分析肿瘤缺氧的动态[18F]-氟米索正电子发射断层扫描(PET)数据的动力学模型。
Phys Med Biol. 2005 May 21;50(10):2209-24. doi: 10.1088/0031-9155/50/10/002. Epub 2005 Apr 27.
8
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.每日摆位变化对头颈部调强放射治疗的影响。
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):779-88. doi: 10.1016/j.ijrobp.2004.07.696.
9
Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.恶性肿瘤中的缺氧与葡萄糖代谢:通过[18F]氟米索硝唑和[18F]氟脱氧葡萄糖正电子发射断层显像进行评估
Clin Cancer Res. 2004 Apr 1;10(7):2245-52. doi: 10.1158/1078-0432.ccr-0688-3.
10
Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings.缺氧前列腺/肌肉氧分压比值可预测前列腺癌患者的生化复发:初步研究结果。
Urology. 2002 Oct;60(4):634-9. doi: 10.1016/s0090-4295(02)01858-7.